July 23, 2018 PR-M07-18-NI-072
LOS ANGELES /PRNewswire/ -- Childhood cancer researchers often depend largely on private funding to get projects off the ground and to move novel treatment approaches to the next phase of testing, ultimately bringing better therapies and cures to the forefront for kids with cancer. In its newest round of grants, the St. Baldrick's Foundation, the largest private funder of childhood cancer research grants, is proud to award 76 grants totaling more than $19.1 million to support physician-scientists studying innovative treatment options in the pediatric cancer space.
Every 2 minutes a child is diagnosed with cancer worldwide. The grants from the St. Baldrick's Foundation deliver on its commitment to support the most promising childhood cancer research, no matter where it takes place.
"At St. Baldrick's, we focus on funding research that has the best potential of giving kids the healthy childhoods they deserve," said Kathleen Ruddy, CEO of the St. Baldrick's Foundation. "I'm proud to say that we have now funded more than a quarter billion dollars since 2005 to support lifesaving childhood cancer research. This achievement would not have been possible without the collective efforts of our amazing volunteers, donors and supporters across the globe. Together, we are leading the charge to take childhood back from cancer."
The following institutions were awarded new grants:
To see the research St. Baldrick's is funding near you, visit the Grants Search page, or to learn more about each grant category visit the Grant Types page on the Foundation's website. The next St. Baldrick's grant cycle will be announced in the fall. For additional information on each grant or to interview a researcher please email traci@stbaldricks.org.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.